{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:15:55Z","timestamp":1772806555162,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801049"],"award-info":[{"award-number":["81801049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Minhang District Natural Science Research Project of Shanghai","award":["2016MHZ55"],"award-info":[{"award-number":["2016MHZ55"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Parkinson\u2019s disease (PD) is a progressive neurodegenerative movement disorder that is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Large-scale meta-analyses of genome-wide association studies (GWAS) have identified few susceptibility loci in patients with sporadic PD. The aim of this study was to investigate the association between\n                      <jats:italic>NMD3<\/jats:italic>\n                      single nucleotide polymorphism (SNP) and symptoms in PD patients in South China.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 217 PD patients were recruited in this study and genotyped by using the SNaPshot technique and the polymerase chain reaction. All subjects were evaluated by the Mini-Mental State Examination (MMSE), Beijing version Montreal Cognitive Assessment (MoCA), Sniffin\u2019 Sticks 16 (SS-16), Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale, 39-item Parkinson\u2019s Disease Questionnaire (PDQ-39) and MDS Unified PD Rating Scale (MDS-UPDRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>NMD3<\/jats:italic>\n                      rs34016896 (C\u2009&gt;\u2009T) carriers have worse cognitive function than wild types (MMSE:\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u00a00.042,\n                      <jats:italic>NMD3<\/jats:italic>\n                      wild type: 27.44\u2009\u00b1\u20092.89,\n                      <jats:italic>NMD3<\/jats:italic>\n                      carriers: 26.31\u2009\u00b1\u20093.79; MoCA:\n                      <jats:italic>p\u2009=<\/jats:italic>\n                      \u00a00.005,\n                      <jats:italic>NMD3<\/jats:italic>\n                      wild type: 23.15\u2009\u00b1\u20094.20,\n                      <jats:italic>NMD3<\/jats:italic>\n                      carriers: 20.75\u2009\u00b1\u20096.68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The recessive and overdominant model of\n                      <jats:italic>NMD3<\/jats:italic>\n                      rs34016896 was associated with cognitive impairment in PD patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-019-1574-1","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T08:02:47Z","timestamp":1578988967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between NMD3 and symptoms of Parkinson\u2019s disease in Chinese patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Hui","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuya","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2433-0293","authenticated-orcid":false,"given":"Zhenzhou","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2147\/NDT.S85380","volume":"11","author":"YM Zou","year":"2015","unstructured":"Zou YM, Liu J, Tian ZY, Lu D, Zhou YY. Systematic review of the prevalence and incidence of Parkinson\u2019s disease in the People\u2019s Republic of China. Neuropsychiatr Dis Treat. 2015;11:1467\u201372.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"1574_CR2","first-page":"377","volume":"48","author":"R B\u00e9n\u00e9","year":"2009","unstructured":"B\u00e9n\u00e9 R, Anti\u0107 S, Budisi\u0107 M, Lisak M, Trkanjec Z, Demarin V, Podobnik-Sarkanji S. Parkinson\u2019s disease. Acta Clin Croat. 2009;48(3):377\u201380.","journal-title":"Acta Clin Croat"},{"issue":"22","key":"1574_CR3","doi-asserted-by":"publisher","first-page":"13972","DOI":"10.1073\/pnas.242594999","volume":"99","author":"K Steece-Collier","year":"2002","unstructured":"Steece-Collier K, Maries E, Kordower JH. Etiology of Parkinson\u2019s disease: genetics and environment revisited. Proc Natl Acad Sci U S A. 2002;99(22):13972\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1574_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards TL, Scott WK, Almonte C, Burt A, Powell EH, Beecham GW, Wang L, Z\u00fcchner S, Konidari I, Wang G, Singer C, Nahab F, Scott B, Stajich JM, Pericak-Vance M, Haines J, Vance JM, Martin ER. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet. 2010;74(2):97\u2013109.","journal-title":"Ann Hum Genet"},{"issue":"9","key":"1574_CR5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/ng.642","volume":"42","author":"TH Hamza","year":"2010","unstructured":"Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA, Payami H. Common genetic variation in the HLA region is associated with lateonset sporadic Parkinson\u2019s disease. Nat Genet. 2010;42(9):781\u20135.","journal-title":"Nat Genet"},{"issue":"9766","key":"1574_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","volume":"377","author":"MA Nalls","year":"2011","unstructured":"International Parkinson Disease Genomics Consortium, Nalls MA, Plagnol V, Hernandez DG, Sharma M, Sheerin UM, Saad M, Sim\u00f3n-S\u00e1nchez J, Schulte C, Lesage S, Sveinbj\u00f6rnsd\u00f3ttir S, Stef\u00e1nsson K, Martinez M, Hardy J, Heutink P, Brice A, Gasser T, Singleton AB, Wood NW. Imputation of sequence variants for identification of genetic risks for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet. 2011;377(9766):641\u20139.","journal-title":"Lancet"},{"issue":"7","key":"1574_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2174\/1389203717666160311121748","volume":"18","author":"M Blanca Ram\u00edrez","year":"2017","unstructured":"Blanca Ram\u00edrez M, Madero-Perez J, Rivero-Rios P, Martinez-Salvador M, Lara Ordonez AJ, Fernandez B, Fdez E, Hilfiker S. LRRK2 and Parkinson\u2019s disease: from lack of structure to gain of function. Curr Protein Pept Sci. 2017;18(7):677\u201386.","journal-title":"Curr Protein Pept Sci"},{"key":"1574_CR8","doi-asserted-by":"publisher","first-page":"24475","DOI":"10.1038\/srep24475","volume":"6","author":"IJ Siddiqui","year":"2016","unstructured":"Siddiqui IJ, Pervaiz N, Abbasi AA. The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication. Sci Rep. 2016;6:24475.","journal-title":"Sci Rep"},{"issue":"10","key":"1574_CR9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamaneurol.2016.2245","volume":"73","author":"MY Davis","year":"2016","unstructured":"Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP. Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease. JAMA Neurol. 2016;73(10):1217\u201324.","journal-title":"JAMA Neurol"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neulet.2014.12.027","volume":"587","author":"ZH Liu","year":"2015","unstructured":"Liu ZH, Guo JF, Li K, Wang YQ, Kang JF, Wei Y, Sun QY, Xu Q, Wang DL, Xia K, Yan XX, Xu CS, Tang BS. Analysis of several loci from genome-wide association studies in Parkinson\u2019s disease in mainland China. Neurosci Lett. 2015;587:68\u201371.","journal-title":"Neurosci Lett"},{"issue":"4","key":"1574_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12031-018-1048-8","volume":"64","author":"Y Chen","year":"2018","unstructured":"Chen Y, Cao B, Ou R, Wei Q, Chen X, Zhao B, Wu Y, Song W, Shang HF. Determining the effect of the HNMT, STK39, and NMD3 polymorphisms on the incidence of Parkinson\u2019s disease, amyotrophic lateral sclerosis, and multiple system atrophy in Chinese populations. J Mol Neurosci. 2018;64(4):574\u201380.","journal-title":"J Mol Neurosci"},{"issue":"7","key":"1574_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.15252\/embj.201696012","volume":"36","author":"AG Malyutin","year":"2017","unstructured":"Malyutin AG, Musalgaonkar S, Patchett S, Frank J, Johnson AW. Nmd3 is a structural mimic of eIF5A, and activates the cpGTPase Lsg1 during 60S ribosome biogenesis. EMBO J. 2017;36(7):854\u201368.","journal-title":"EMBO J"},{"issue":"4","key":"1574_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1001\/jamaneurol.2013.6222","volume":"71","author":"JM Shulman","year":"2014","unstructured":"Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol. 2014;71(4):429\u201335.","journal-title":"JAMA Neurol"},{"issue":"12","key":"1574_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30(12):1591\u2013601.","journal-title":"Mov Disord"},{"issue":"15","key":"1574_CR15","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N. Movement disorder society UPDRS revision task force. movement disorder society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDSUPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370.","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"1574_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jns.2012.01.033","volume":"316","author":"W Chen","year":"2012","unstructured":"Chen W, Chen S, Kang WY, Li B, Xu ZM, Xiao Q, Liu J, Wang Y, Wang G, Chen SD. Application of odor identification test in Parkinson\u2019s disease in China: a matched case-control study. J Neurol Sci. 2012;316(1\u20132):47\u201350.","journal-title":"J Neurol Sci"},{"issue":"8","key":"1574_CR17","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.sleep.2014.03.020","volume":"15","author":"SS Shen","year":"2014","unstructured":"Shen SS, Shen Y, Xiong KP, Chen J, Mao CJ, Huang JY, Li J, Han F, Liu CF. Validation study of REM sleep behavior disorder questionnaire-Hong Kong (RBDQ-HK) in east China. Sleep Med. 2014;15(8):952\u20138.","journal-title":"Sleep Med"},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fnagi.2018.00402","volume":"10","author":"G Li","year":"2018","unstructured":"Li G, Cui S, Du J, Liu J, Zhang P, Fu Y, He Y, Zhou H, Ma J, Chen S. Association of GALC, ZNF184, IL1R2 and ELOVL7 with Parkinson\u2019s disease in southern Chinese. Front Aging Neurosci. 2018;10:402.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"1574_CR19","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1128\/MCB.19.3.2389","volume":"19","author":"JH Ho","year":"1999","unstructured":"Ho JH, Johnson AW. NMD3 encodes an essential cytoplasmic protein required for stable 60S ribosomal subunits in Saccharomyces cerevisiae. Mol Cell Biol. 1999;19(3):2389\u201399.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"1574_CR20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1083\/jcb.201006033","volume":"189","author":"M Oeffinger","year":"2010","unstructured":"Oeffinger M. Joining the interface: a site for Nmd3 association on 60S ribosome subunits. J Cell Biol. 2010;189(7):1071\u20133.","journal-title":"J Cell Biol"},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.nbd.2014.10.003","volume":"73","author":"H Kang","year":"2015","unstructured":"Kang H, Shin JH. Repression of rRNA transcription by PARIS contributes to Parkinson\u2019s disease. Neurobiol Dis. 2015;73:220\u20138.","journal-title":"Neurobiol Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1574-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T19:26:03Z","timestamp":1610479563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1574-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.10047\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.10047\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.10047\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Research Ethics Committee, Renji Hospital, Shanghai, China. All participants signed consent forms. It also adhered to international guidelines established for scientific research involving human participants as established by the Declaration of Helsinki and its subsequent amendments.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}